fbpx

Programme

Programme at a glance

Pre-Summit Workshops

Wednesday 18 March 2020

Main Summit

Thursday 19 March 2020

View and print the Pre-Summit and Main Summit Workshops Programme at a glance.(PDF)


Full Programme

MedCan Summit has been approved for CME by the Royal New Zealand College of General Practitioners and the Pharmaceutical Society of New Zealand. For more information, click here

Expand All +
  • Main Summit: Thursday 19 March 2020


  • Pre-Summit Workshops: Wednesday 18 March 2020


  • Hear from the Goodfather of cannabis, Raphael Mechoulam, who has been studying THC and CBD for more than 30 years.
    Medicine/CPD

  • This talk lays the groundwork of the endocannabinoid system (deficiency syndrome), synthetics, phytocannabinoids (plant, cannabinoids CBD vs CB2, terpenes) delivery mechanisms and contraindications
    Medicine/CPD
    Science

  • Dr Spelman will help you understand the science behind plant constituents, and review the pharmacokinetics and pharmacodynamics of cannabis, which will enable a better understand of how to use cannabis in a clinical setting.
    Medicine/CPD
    Industry
    Science

  • Learn about the guidelines for cultivating medicinal cannabis in New Zealand from 1 April 2020.
    Industry

  • Understand the history of cannabis and the current issues with regards to the stigma of cannabis.
    Medicine/CPD

  • Hear how international regulation could impact the New Zealand medicinal cannabis industry.
    Industry

  • Learn the chemistry of cannabis, including the cannabinoids, trepenoids and flavonoids.
    Science

  • Understand the primary business principles required to initiate and grow a successful business within the emerging cannabis industry.
    Industry

  • Dr Arboleda will share current evidence and practical experience in how cannabiniod-based medicines are being use to treat chronic pain and in palliative care management.
    Medicine/CPD

  • Hear about the use of natural product scaffolds for the development of new drugs for epilepsy, neuropathic pain, depression, anxiety, substance abuse, and schizophrenia.
    Science

  • Gain an understanding of intellectual property, including infringement risk, how to avoid losing valuable IP, and how to identify important IP assets such as patents, trademarks, know-how and copyrights.
    Science

  • Hear from the Goodfather on medicinal cannabis use in the clinical setting.
    Medicine/CPD

  • Hear Dr Washer's perspective on the unexpected journey from biotech to cannabis medicine and back again.
    Industry

  • Lunch, exhibition and networking

  • Learn about the implications of prescribing medicinal cannabis in New Zealand from 1 April 2020 as outlined in the new Medicinical Cannabis Regulations.
    Medicine/CPD

  • Hear from the Goodfather of cannabis on areas of future scientific research
    Science

  • Hear Tom Forrest's reflection on the challenges and opportunities from the cultivation perspective.
    Industry

  • How to use medicinal cannabis in real world practice, including how to use it to treat chronic pain, anxiety, insominia and opioid overuse.
    Medicine/CPD

  • Learn about the options, current industrial practice and future trends for the extraction of cannabis.
    Industry

  • Understand the development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit.
    Science

  • The panel will discuss case studies of medicinal cannabis clinical trials.
    Science

  • Dr Ware will dispell myths about THC, the most researched cannabinoid for therapeutic benefits.
    Medicine/CPD

  • Learn about patients perspective on cannabis use, the data collected on effectiveness and adverse effects of medicinal cannabis.
    Science

  • As medicinal cannabis is a new industry for New Zealand, how can we learn from other countries about regulation?
    Industry

  • Get an overview of pharmaceutical cannabis including safety, clinical evidence, pharmacology, pharmacokinetics, interactions, contraindications and dosage forms.
    Medicine/CPD

  • Patients will share their experiences of using medicinal cannabis.
    Medicine/CPD
    Policy

  • Facilitator & Asia/Pacific - Martin Woodbridge, International Consultant, Woodbridge Research USA/Canada - Brent Zettl, President and CEO, ZYUS Life Sciences Inc. Recent emerging environments - Rhys Cohen, Principal Consultant, FreshLeaf Analytics Colombia, Mexico, Peru, Argentina, Chile, Brazil, Canada - Dr Maria-Fernanda Arboleda MD, International Director Medical Services, Khiron Life Sciences Corp
    Medicine/CPD
    Industry
    NZ Economy
    Policy
    Science
    Technology

  • Meet and discuss with industry along the supply chain seed to sale
    Industry
    Science
    Technology

  • The role of clinical trials and evidence-based medicine in the medicinal cannabis sector and New Zealand’s role
    Medicine/CPD

  • Round table discussions facilitated by experts covering the following topics; Growing, Processing and Manufacturing, Quality and Testing, Formulation & Regulations
    Industry
    Science
    Technology

  • Round table discussions facilitated by experts covering the following topics; Growing, Processing and Manufacturing, Quality and Testing, Formulation & Regulations
    Industry